Mazen Iqbal
Cardiovascular Disease · Monroe, LANPI 1720502735
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (44.0%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 22 manufacturers reported payments, led by Abbott at 34.7% of the total. Reporting peaked in 2023 at $29,842 and has fallen 62.7% since, to $11,139 in 2025. Among cardiovascular disease clinicians in LA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 360 payments — averaging $226.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$28K
- Biotronik Inc.$21K
- Medtronic$18K
- Biosense Webster, Inc.$6K
- Medical Device Business Services, Inc.$4K
- Boston Scientific$3K
- plus $1K from 16 others
What the payments were for
- Grants$35,87544%
- Travel & lodging$27,86034%
- Food & beverage$16,40920%
- Education$1,4372%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 40 | $28,336 |
| Biotronik Inc. | 133 | $21,155 |
| Medtronic | 52 | $17,707 |
| Biosense Webster, Inc. | 49 | $6,285 |
| Medical Device Business Services, Inc. | 30 | $3,854 |
| Boston Scientific | 23 | $2,869 |
| Abiomed | 5 | $371 |
| Amgen | 6 | $324 |
| Cardiva Medical, Inc. | 7 | $305 |
| Irhythm Technologies, Inc. | 1 | $89 |
| Philips North America LLC | 2 | $61 |
| Terumo Medical Corporation | 2 | $43 |
| Shockwave Medical, Inc | 1 | $24 |
| Sanofi | 1 | $23 |
| E.r. Squibb & Sons, L.L.C. | 1 | $23 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $20 |
| AstraZeneca | 1 | $18 |
| Merck | 1 | $16 |
| Itamar Medical Inc | 1 | $16 |
| Novo Nordisk | 1 | $15 |
| Bristol Myers Squibb | 1 | $15 |
| Teleflex LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Carto 3$8,130
- ASSURITY$5,625
- TACTICATH ABLATION CATHETER, SENSOR ENABLED$4,500
- Solia$4,409
- BioMonitor$4,315
- Acticor 7 VR-T DX$3,725
- Edora 8 DR-T$3,202
- Acticor$2,488
- Edora$2,488
- Rivacor$2,488
- Rivacor 7 DR-T$2,021
- AVEIR$2,013
- Micra$1,268
- Sentus$1,158
- S-ICD System Magnet$904
- ENSITE$703
- Plexa ProMRI$667
- ENSITE PRECISION$608
- Plexa$491
- Watchman$469
How this compares
$81,581 in reported general payments places this provider in the 95th percentile of 281 cardiovascular disease providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pantoprazole Sodium | 37 | $143 |
| Metoprolol Tartrate | 11 | $42 |
| Furosemide | 18 | $19 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Monroe
- Imran ChaudryMonroe$202K
- Keith FerdinandNew Orleans$239K
- Carl LavieNew Orleans$228K
- Corey FosterLake Charles$158K
- George KaramBaton Rouge$110K
- Harry HawthorneAlexandria$89K
- Darrell SoletMorgan City$81K
- Ghiath MikdadiHammond$76K
- Samuel StaggHouma$70K
- Alexandra SanchezNew Orleans$69K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.